A Good Start to Shed More Light on the Relationship Between Glycemic Traits, Diabetes Mellitus, and Cerebrovascular Disease
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Ischemic stroke is a heterogeneous disease with numerous underlying pathologies contributing to its pathogenesis. The association between diabetes mellitus and ischemic stroke is well established. Population-based studies suggest that diabetes is one of the most important modifiable risk factors for stroke. Having type 2 diabetes mellitus (T2DM) alone increases the risk of stroke 1.5- to 4-fold and is associated with unfavorable clinical outcomes.1 On the other hand, individuals presenting with ischemic stroke are more likely to have diabetes, with a prevalence reaching nearly 30%.2 The relative contribution of diabetes to the risk of different ischemic stroke subtypes is, however, less well known. Furthermore, there is conflicting evidence on the association of hyperglycemia in the prediabetic range with an elevated stroke risk.3,4 Whether other metabolic markers of pathogenic states such as insulin resistance or β-cell dysfunction alone can be considered risk factors for ischemic stroke is still a matter of debate.
Footnotes
Go to Neurology.org/Nhttps://n.neurology.org/lookup/doi/10.1212/WNL.0000000000011557 for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
See page 607
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Diabetes Mellitus, Glycemic Traits, and Cerebrovascular DiseaseA Mendelian Randomization StudyMarios K. Georgakis, Eric L. Harshfield, Rainer Malik et al.Neurology, January 25, 2021 -
Article
Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypesMendelian randomization studySusanna C. Larsson, Robert A. Scott, Matthew Traylor et al.Neurology, June 30, 2017 -
Article
Serum magnesium and calcium levels in relation to ischemic strokeMendelian randomization studySusanna C. Larsson, Matthew Traylor, Stephen Burgess et al.Neurology, January 25, 2019 -
Article
Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypesMarios K. Georgakis, Dipender Gill, Alastair J.S. Webb et al.Neurology, July 01, 2020